Great Posts, both of these should be stickied. The summary gets all the key points, great for a quick reference of all that LP said. Please sticky both.
Does AI address why they have not one person on the BOD who has pertinent recent immunotherapy experience bringing a product through to commercial success? Who are these great consultants that dragged the filing through a rewrite adding a year to submission? Just tired of this crew and venting. Finish something that brings in revenue!
Market Data 
Markets 
AI
